Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Donnenberg_AD:

Search results

Items: 1 to 20 of 131

1.

Oncologic Safety of Fat Grafting for Autologous Breast Reconstruction in an Animal Model of Residual Breast Cancer.

Silva MMA, Kokai LE, Donnenberg VS, Fine JL, Marra KG, Donnenberg AD, Neto MS, Rubin JP.

Plast Reconstr Surg. 2019 Jan;143(1):103-112. doi: 10.1097/PRS.0000000000005085.

PMID:
30589782
2.

Proteomic Profiling of Native Unpassaged and Culture-Expanded Mesenchymal Stromal Cells (MSC).

Moravcikova E, Meyer EM, Corselli M, Donnenberg VS, Donnenberg AD.

Cytometry A. 2018 Jul;93(9):894-904. doi: 10.1002/cyto.a.23574. Epub 2018 Sep 13.

PMID:
30211967
3.

Flow cytometric detection of most proteins in the cell surface proteome is unaffected by trypsin treatment.

Donnenberg VS, Corselli M, Normolle DP, Meyer EM, Donnenberg AD.

Cytometry A. 2018 Aug;93(8):803-810. doi: 10.1002/cyto.a.23525. Epub 2018 Aug 14.

PMID:
30107080
4.

Antibody-based cell-surface proteome profiling of metastatic breast cancer primary explants and cell lines.

Donnenberg VS, Zhang JJ, Moravcikova E, Meyer EM, Lu H, Carson CT, Donnenberg AD.

Cytometry A. 2018 Apr;93(4):448-457. doi: 10.1002/cyto.a.23300. Epub 2018 Mar 2.

PMID:
29498809
5.

An Animal Model of Local Breast Cancer Recurrence in the Setting of Autologous Fat Grafting for Breast Reconstruction.

Tsuji W, Valentin JE, Marra KG, Donnenberg AD, Donnenberg VS, Rubin JP.

Stem Cells Transl Med. 2018 Jan;7(1):125-134. doi: 10.1002/sctm.17-0062.

6.

BOK displays cell death-independent tumor suppressor activity in non-small-cell lung carcinoma.

Moravcikova E, Krepela E, Donnenberg VS, Donnenberg AD, Benkova K, Rabachini T, Fernandez-Marrero Y, Bachmann D, Kaufmann T.

Int J Cancer. 2017 Nov 15;141(10):2050-2061. doi: 10.1002/ijc.30906. Epub 2017 Aug 7.

7.

Classification and Functional Characterization of Vasa Vasorum-Associated Perivascular Progenitor Cells in Human Aorta.

Billaud M, Donnenberg VS, Ellis BW, Meyer EM, Donnenberg AD, Hill JC, Richards TD, Gleason TG, Phillippi JA.

Stem Cell Reports. 2017 Jul 11;9(1):292-303. doi: 10.1016/j.stemcr.2017.04.028. Epub 2017 May 25.

8.

The Mesenchymal State Predicts Poor Disease-Free Survival in Resectable Non-Small Cell Lung Cancer.

Mehta K, Moravcikova E, McFall D, Luketich JD, Pennathur A, Donnenberg AD, Donnenberg VS.

Ann Thorac Surg. 2017 Jul;104(1):321-328. doi: 10.1016/j.athoracsur.2017.01.091. Epub 2017 May 9.

9.

A depleting antibody toward sca-1 mitigates a surge of CD34(+)/c-kit(+) progenitors and reduces vascular restenosis in a murine vascular injury model.

Tillman BW, Kelly J, Richards TD, Chen AF, Donnenberg AD, Donnenberg VS, Tzeng E.

J Vasc Surg. 2016 Oct;64(4):1084-92. doi: 10.1016/j.jvs.2015.05.002.

10.

Neither epithelial nor mesenchymal circulating tumor cells isolated from breast cancer patients are tumorigenic in NOD-scid Il2rgnull mice.

Donnenberg VS, Huber A, Basse P, Rubin JP, Donnenberg AD.

NPJ Breast Cancer. 2016 Mar 9;2:16004. doi: 10.1038/npjbcancer.2016.4. eCollection 2016.

11.

The use of simultaneous confidence bands for comparison of single parameter fluorescent intensity data.

Kim D, Donnenberg VS, Wilson JW, Donnenberg AD.

Cytometry A. 2016 Jan;89(1):89-97. doi: 10.1002/cyto.a.22733. Epub 2015 Sep 25.

12.

The cell-surface proteome of cultured adipose stromal cells.

Donnenberg AD, Meyer EM, Rubin JP, Donnenberg VS.

Cytometry A. 2015 Jul;87(7):665-74. doi: 10.1002/cyto.a.22682. Epub 2015 Apr 30.

13.

Coping with artifact in the analysis of flow cytometric data.

Donnenberg VS, Donnenberg AD.

Methods. 2015 Jul 1;82:3-11. doi: 10.1016/j.ymeth.2015.03.012. Epub 2015 Mar 28.

PMID:
25823849
14.

Stem cell state and the epithelial-to-mesenchymal transition: Implications for cancer therapy.

Donnenberg VS, Donnenberg AD.

J Clin Pharmacol. 2015 Jun;55(6):603-19. doi: 10.1002/jcph.486. Epub 2015 Apr 7. Review.

PMID:
25708160
15.

Dynamic Interactions Between Cancer Stem Cells And Their Stromal Partners.

Park TS, Donnenberg VS, Donnenberg AD, Zambidis ET, Zimmerlin L.

Curr Pathobiol Rep. 2014 Mar 1;2(1):41-52.

16.

Activation of human mesenchymal stem cells impacts their therapeutic abilities in lung injury by increasing interleukin (IL)-10 and IL-1RN levels.

Bustos ML, Huleihel L, Meyer EM, Donnenberg AD, Donnenberg VS, Sciurba JD, Mroz L, McVerry BJ, Ellis BM, Kaminski N, Rojas M.

Stem Cells Transl Med. 2013 Nov;2(11):884-95. doi: 10.5966/sctm.2013-0033. Epub 2013 Oct 2.

17.

CD34 affinity pheresis attenuates a surge among circulating progenitor cells following vascular injury.

Harbuzariu A, Kim J, Meyer EM, Donnenberg AD, Tillman BW.

J Vasc Surg. 2014 Jun;59(6):1686-94. doi: 10.1016/j.jvs.2013.05.043. Epub 2013 Jul 19.

18.

Prevalence of endogenous CD34+ adipose stem cells predicts human fat graft retention in a xenograft model.

Philips BJ, Grahovac TL, Valentin JE, Chung CW, Bliley JM, Pfeifer ME, Roy SB, Dreifuss S, Kelmendi-Doko A, Kling RE, Ravuri SK, Marra KG, Donnenberg VS, Donnenberg AD, Rubin JP.

Plast Reconstr Surg. 2013 Oct;132(4):845-58. doi: 10.1097/PRS.0b013e31829fe5b1.

19.

Mesenchymal stem cell secretome and regenerative therapy after cancer.

Zimmerlin L, Park TS, Zambidis ET, Donnenberg VS, Donnenberg AD.

Biochimie. 2013 Dec;95(12):2235-45. doi: 10.1016/j.biochi.2013.05.010. Epub 2013 Jun 5. Review.

20.

KIT (CD117) expression in a subset of non-small cell lung carcinoma (NSCLC) patients.

Donnenberg AD, Zimmerlin L, Landreneau RJ, Luketich JD, Donnenberg VS.

PLoS One. 2012;7(12):e52885. doi: 10.1371/journal.pone.0052885. Epub 2012 Dec 20.

Supplemental Content

Loading ...
Support Center